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Epigenome-wide association study 
of asthma and wheeze characterizes loci 
within HK1
Todd M. Everson1,2, Hongmei Zhang3, Gabrielle A. Lockett4, Akhilesh Kaushal5, Melinda Forthofer1,6, 
Susan L. Ewart7, Kimberley Burrows8, Caroline L. Relton8, Gemma C. Sharp8, A. John Henderson9, 
Veeresh K. Patil11, Faisal I. Rezwan4, S. Hasan Arshad10,11,12, John W. Holloway4,10 and Wilfried Karmaus3* 
Abstract 
Background: To identify novel epigenetic markers of adolescent asthma and replicate findings in an independent 
cohort, then explore whether such markers are detectable at birth, predictive of early-life wheeze, and associated with 
gene expression in cord blood.
Methods: We performed epigenome-wide screening with recursive random forest feature selection and internal 
validation in the IOW birth cohort. We then tested whether we could replicate these findings in the independent 
cohort ALSPAC and followed-up our top finding with children of the IOW cohort.
Results: We identified 10 CpG sites associated with adolescent asthma at a 5% false discovery rate (IOW, n = 370), five 
of which exhibited evidence of associations in the replication study (ALSPAC, n = 720). One site, cg16658191, within 
HK1 displayed particularly strong associations after cellular heterogeneity adjustments in both cohorts  (ORIOW = 0.17, 
95% CI 0.04–0.57)  (ORALSPAC = 0.57, 95% CI 0.38–0.87). Additionally, higher expression of HK1 (OR = 3.81, 95% CI 
1.41–11.77) in cord blood was predictive of wheezing in infancy (n = 82).
Conclusion: We identified novel associations between asthma and wheeze with methylation at cg16658191 and the 
expression of HK1, which may serve as markers of, predictors of, and potentially etiologic factors involved in asthma 
and early life wheeze.
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Background
Asthma is a common chronic respiratory disease 
particularly among children [1], causing substantial 
health care costs [2]. Asthma has complex 
pathophysiology [3], phenotypic variability [4], and is 
polygenic with a high heritable component, yet GWAS 
discoveries can only explain a small fraction of asthma 
variance [5]. Epigenetic mechanisms, which regulate 
gene expression potential [6], have received attention 
in studies of asthma because these mechanisms may be 
influenced via environmental exposures, particularly 
exposures that occur in utero [7, 8]. One of the most 
studied epigenetic mechanism is DNA methylation 
(DNAm), which is the covalent addition of a methyl 
group to the DNA at a cytosine residue that is followed 
by a guanine (CpG site); acting as an important regulator 
of gene transcription [6].
Recent epigenetic epidemiology studies have 
associated DNAm in blood with current asthma and/
or wheeze in childhood and adolescence [9, 10], in cord 
blood with childhood asthma [11], and as a possible 
mediator between maternal and offspring asthma 
[12]. DNA methylation has also been implicated as a 
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possible mediator of the relationships between both 
environmental and genetic factors with asthma. For 
instance, environmental exposure to air pollution is a 
risk factor for asthma exacerbations as well as asthma 
onset [13]. Recent studies have shown that air pollution 
is associated with differential DNAm of TET1 [14] and 
FOXP3 [15], and that differential methylation of these 
genes associates with asthma, suggesting that epigenetic 
regulation has a potential mediating role. Additionally, 
GSDMB and ORMDL3 are two well-recognized asthma 
susceptibility genes [16], and recent studies have 
shown that DNAm may be a mediator between genetic 
variation and the expression of these genes [17]. These 
studies provide supportive evidence that epigenetic 
mechanisms may be involved in the etiology of asthma, 
potentially as intermediates between recognized risk 
factors and the development of symptoms. A recent 
epigenome-wide meta-analysis of multiple European 
cohorts identified robust associations between asthma 
and blood DNA methylation throughout childhood 
(4–8  years of age), which retained strong associations 
with asthma status among isolated eosinophils 
and these epigenetic signatures were indicative of 
eosinophil and cytotoxic cell activation [18]. The 
above studies highlight the mounting evidence that 
differential epigenetic regulation of specific genes 
contributes to asthma etiology, and that epigenome-
wide approaches have led to the identification of 
novel asthma-associated epigenomic loci. Performing 
additional EWAS in independent populations with 
different ages and different asthmatic phenotypes 
can improve our understanding of which loci are 
informative across multiple populations, how these 
epigenetic variations relate to asthma throughout 
the life course, and whether their methylation levels 
correlate with specific phenotypic characteristics, such 
as inflammation or lung function.
In the current study, we performed an EWAS using 
both a standard CpG-by-CpG approach as well as an 
innovative feature selection method to identify novel 
epigenetic markers of prevalent asthma in 18  years 
olds, investigated if the identified loci were predictive 
of early-life wheeze, and whether DNA methylation 
at these loci were related to gene expression. We first 
conducted an exploratory epigenome-wide screening 
study of DNAm in whole blood within the Isle of Wight 
(IOW) birth cohort, followed by a replication study 
within the Avon Longitudinal Study of Parents and 
Children (ALSPAC). Then, with data from the offspring 
of the IOW birth cohort participants, we tested whether 
the same associations exist between cord blood DNAm 
and wheeze without upper respiratory viral infection 
(cold) within the 1st  year of life, followed by testing for 
associations between gene expression with DNAm and 
with infant wheeze.
Methods
The Isle of Wight birth cohort
The Isle of Wight (IOW) birth cohort is an unselected 
birth cohort of children born between January 1, 1989 
and February 28, 1990 in Isle of Wight, UK. Details about 
the birth cohort have been described in detail elsewhere 
[19]. After exclusion of adoptions and prenatal deaths, 
1456 children were enrolled and followed-up through 
to 18  years of age (n = 1313; 90.2% retention). At each 
follow-up, participants were evaluated for manifestations 
of allergic disease and administered detailed 
questionnaires, including study specific questions, as 
well as questions derived from the International Study 
of Asthma and Allergies in Childhood (ISAAC), the 
most extensive international study of asthma, which lead 
to the development and validation of questions about 
asthma and wheeze symptoms [20]. Ethical approval was 
obtained from National Research Ethics Service, NRES 
Committee South Central—Southampton B for the 
18-year follow-up (06/Q1701/34) and NRES Committee 
South Central—Hampshire B (09/H0504/129) for 
the follow-up of IOW participants’ offspring; written 
informed consent was provided by the infants’ parents.
At the 18-year follow-up a subset of participants 
(n = 370) were selected to take part in an epigenetic 
screening; this sample is referred to as the ‘IOW F1 
sample’ herein. The primary outcome for this study 
was current asthma defined as having an asthma 
diagnosis and self-reported wheeze and/or use of asthma 
medications in the previous 12 months. Those attending 
the 18  years follow-up in person also performed 
spirometry and fractional-exhaled nitric oxide (FeNO), 
which were in accordance with American Thoracic 
Society (ATS) guidelines [21, 22], as well as allergen 
sensitization via skin prick tests (SPTs). Lung function 
assessments were performed using a Koko Spirometer 
and software with a desktop portable device (PDS 
Instrumentation, Louisville, USA). FeNO measurements 
(Niox mino, Aerocrine AB, Solna, Sweden) were obtained 
prior to spirometric assessments. Atopy was defined 
as having at least one positive SPT among 11 allergens 
(cows’ milk, hens’ egg, peanut, cod, house dust mite, cat, 
dog, Alternaria alternata, Cladosporium herbarium, 
grass pollen mix, and tree pollen mix). DNA was 
extracted from peripheral blood collected at the 18-year 
follow-up using a salting out procedure.
The IOW offspring (IOW F2 sample) are being enrolled 
in the IOW 3rd Generation study through ongoing 
recruitment since 2010. To date, 390 newborns have been 
enrolled; cord blood samples were collected at birth and 
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have been processed on 111 newborns for DNAm and 
82 newborns for gene expression. Questionnaires about 
allergy and wheeze symptoms were administered to the 
parents at follow-up visits 3, 6, and 12 months after birth. 
The primary dependent variable for this sample was 
parent reported wheeze occurring when the infant had 
no symptoms of a cold. We also investigated any reported 
wheeze as an alternate outcome.
The ALSPAC cohort
The Avon Longitudinal Study of Parents and Children 
(ALSPAC) is a large, prospective cohort study based 
in the South West of England. In total, 14,541 pregnant 
women resident in Avon, UK with expected delivery 
dates between 1st April 1991 and 31st December 1992 
were initially enrolled; 13,988 children were alive at 1 year 
[23, 24]. Ethical approval for the study was obtained 
from the ALSPAC Ethics and Law Committee and the 
Local Research Ethics Committees; written informed 
consent was provided by all participants. Self-completed 
questionnaires were administered during pregnancy 
and then at regular intervals. Current asthma status was 
obtained around the age of 17 years, defined as a reported 
doctor’s diagnosis of asthma in addition to reported 
wheezing, asthma or the use of asthma medication in 
the previous 12 months. 5036 adolescents had complete 
phenotype data of which, 720 also had DNA methylation 
data from whole blood collected at an average age of 
17  years. Genome-wide methylation measurements 
were conducted at the University of Bristol as part of 
Accessible Resource for Integrated Epigenomic Studies 
(ARIES) project (http://www.aries epige nomic s.org.uk) 
[25]. For the purposes of this study, multiple births and 
children of non-white ethnicity were excluded due to 
small numbers.
DNA methylation arrays
In the IOW F1 sample (18  years of age), IOW F2 
sample (cord blood), and ALSPAC sample (17  years 
of age) DNAm was assessed genome-wide using the 
Illumina  Infinium® HumanMethylation450k BeadChip 
(Illumina, Inc., CA, USA). The details of data processing 
steps  are provided in Additional file  1: Method S1. 
Briefly, quality control and preprocessing methods for 
both cohorts included background correction, probe-
type standardization, batch effect adjustments, and 
exclusion of potentially problematic probes. Methylation 
levels were calculated as beta (β) values, which can be 
interpreted as percent methylation. Because β-values 
can suffer from severe heteroscedasticity, M-values were 
calculated via  log2(β/(1 − β)) which better approximate 
a normal distribution. Cellular heterogeneity of blood 
samples was assessed by estimating the proportions of 
 CD8+ T-cells,  CD4+ T-cells, natural killer cells, B-cells, 
monocytes, eosinophils and other granulocytes [26, 
27] via the estimateCellCounts function in R. These 
proportions were included in our regression models as 
potential confounders of the relationship between DNA 
methylation and current asthma.
Gene expression array
At birth, IOW F2 cord blood samples were collected 
into PAXgene Bone Marrow RNA Tubes and RNA 
extracted using PAXgene RNA kits (PreAnalytiX GmbH, 
Switzerland). RNA integrity was verified with the 
Agilent 2100 Bioanalyzer system. Genome-wide mRNA 
expression was assessed via one color (Cy3) experiments 
with the Agilent (Agilent Technologies, Santa Clara, 
CA) SurePrint G3 Human Gene Expression  8 × 60  k 
v2 microarray kits. Array content was sourced from 
RefSeq, Ensembl, UniGene, and GenBank databases 
and provides full coverage of the human transcriptome 
in 50,599 biological features (including replicate probes 
and control probes). The oligos were 60mer in length and 
each transcript was tagged at least once and some had 
multiple tagging oligos for genes with documented splice 
variants. Data QC indices and analyses were performed 
with Agilent GeneSpring software. These data were then 
percent shift normalized and  log2-transformed.
Statistical analyses (discovery—IOW F1)
We randomly divided the IOW F1 (18  years of age) 
sample into two independent sub-samples. The stage-1 
data  (nS1 = 91) were used for random forest (RF) feature 
selection because RFs rely on few statistical assumptions, 
are efficient with high-dimensional data, are robust to 
outliers and noise, and produce measures of variable 
importance [28, 29]. This feature selection technique 
was utilized in a recent epigenetic study of atopy that 
yielded many replicable loci [30]. The RF algorithm has 
a tendency to produce a predictor that is overfit to the 
supplied data; however, in our study RF was applied 
to select features based on variable importance rather 
than prediction. In addition, the RF algorithm was only 
applied to a subset of the IOW data to further diminish 
the possibility of overfitting, allowing us to examine the 
associations between DNAm and asthma in a statistically 
independent dataset. The stage-2 sample  (nS2 = 279) was 
larger to retain greater power, which was necessary for 
hypothesis testing and multiple testing adjustment.
Recursive RF feature selection was implemented on 
the stage-1 sample  (ns1 = 91) to select the CpGs most 
informative for asthma. We utilized balanced sampling, 
tested 10% of predictors per node (mtry = 0.10) and grew 
forests with 7500 trees (ntree = 7500). We implemented 
the RF recursively: (1) ran the RF algorithm on all available 
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predictors (248,336 CpGs) via the randomForest package 
in R, (2) extracted out-of-bag (OOB) misclassification 
rates and variable importance measures (VIMs), (3) 
sorted the predictors by their VIMs, (4) excluded half of 
the predictors with the smallest VIMs, and (5) repeated 
the sequence until the asthma-specific misclassification 
levelled off. Predictors from the final iteration were 
selected for stage-2 analyses.
M-values for the selected CpGs were tested for their 
associations with asthma status with logistic regression 
after trimming potential strong outliers identified with 
adjusted boxplots. We generated false discovery rate 
(FDR) adjusted p-values [31] via the q-value package in R; 
CpGs within a 5% FDR (q-values < 0.05) were considered 
‘discovered’ and were candidates for the replication study.
Finally, we also performed a traditional EWAS 
regressing the beta-values for each individual loci on 
asthma status in unadjusted linear models, and models 
adjusted for sex,  CD4+ T-cells,  CD8+ T-cells, monocytes, 
eosinophils, natural killer, and granulocytes. Models that 
produced association within a 5% FDR (q-values < 0.05) 
were considered statistically significant.
Statistical analyses (independent replication—ALSPAC)
Candidate CpGs were tested for their associations with 
asthma in the independent cohort, ALSPAC (N = 720). 
To assess consistency of associations, results from the 
ALSPAC cohort were compared to results from the full 
IOW F1 sample (N = 370) using two logistic regression 
models for each CpG site: a crude model between 
M-values and asthma, and a second model adjusting for 
sex and estimated cell-type proportions of  CD8+ T-cells, 
 CD4+ T-cells, natural killer cells, B-cells, monocytes, 
eosinophils and other granulocytes, which were estimated 
from the methylation array data [26, 27]. ALSPAC also 
included batch variables (Additional file  1: Method S2), 
to adjust for technical variations across the DNAm arrays. 
Statistical significance was determined at α of 0.05.
Statistical analyses (functional validation—IOW F2)
Among the successfully replicated loci, wheeze without 
cold and any wheeze were modeled with logistic 
regression. This included all newborns for which at least 
one infant follow-up visit had been completed (n = 111 
for DNAm models and n = 82 for expression models). 
Cord blood proportions of  CD8+ T-cells,  CD4+ T-cells, 
natural killer cells, B-cells, monocytes, granulocytes, 
and nucleated red blood cells (nRBCs) were estimated 
via the estimateCellCounts function [26] using a cord 
blood reference panel [32]. We adjusted for season of 
birth, infant sex, and cell-type proportions. Statistical 
significance was determined at α of 0.05.
Results
Sample characteristics and study flow chart
A flowchart of all analyses is provided in Fig.  1. The 
subjects in the IOW F1 discovery sample were all 
18  years old, predominantly female (66.2%) and 13.9% 
(n = 51) of participants were asthmatic. Asthmatics were 
more likely to be atopic (66.0% vs 29.5%), have lower 
 FEV1/FVC Ratio (means: 0.83 vs. 0.88), greater FeNO 
(medians: 21.0 vs 14.0) and have higher proportions of 
B-cells (0.046 vs 0.039) and eosinophils (0.045 vs 0.021) 
(Table  1). The average age of subjects in the ALSPAC 
sample was 17  years old; 16.7% of the ALSPAC sample 
had asthma and 56.3% of participants were female. The 
IOW stage-1 and stage-2 samples, utilized for feature 
selection and internal validation respectively, had similar 
distributions of all covariates (Additional file 2: Table S1).
Discovery phase (stage‑1 feature selection)
Recursive RF feature selection was implemented on 
the stage-1 sub-sample  (ns1 = 91), with a starting set of 
248,336 CpG sites. The asthma-specific misclassification 
rates levelled off at the 12th iteration of the recursive 
RF algorithm, meaning that further reductions in the 
number of features would result in loss of information 
about asthma-associated loci. Thus, the 121 features 
(CpG sites) included in the 12th iteration (Additional 
file 3: Figure S1) were selected for stage-2 analysis.
Discovery phase (stage‑2 logistic regression)
The stage-2 analysis was performed in an independent 
sub-sample  (ns2 = 279), to test the associations between 
DNA methylation and asthma at the 121 selected CpG 
sites with logistic regression. Of the 121 CpGs, 10 were 
associated with asthma at a 5% FDR (q-values < 0.05) 
(Additional file  2: Table  S2). For all 10 sites, lower 
methylation was associated with greater odds of asthma. 
Adjustment for cellular heterogeneity substantially 
attenuated many of the parameter estimates and none of 
the adjusted models retained 5% FDR-significant q-values. 
However, the parameter estimates for the top five hits 
were mostly unperturbed and retained at least nominally 
significant p-values (< 0.05); in the case of cg16658191 and 
cg25578728, the magnitude of the associations became 
stronger after cell-mixture adjustment.
Replication analysis in ALSPAC
We then aimed to see whether the associations observed 
in IOW could be replicated in an independent cohort, 
ALSPAC. To compare associations between the IOW and 
ALSPAC cohorts, we produced odds ratios (ORs) and 95% 
confidence intervals (CIs) using the pooled IOW samples 
from stage-1 and stage-2 (IOW F1 n = 370) (Table 2) and 
Page 5 of 12Everson et al. Allergy Asthma Clin Immunol           (2019) 15:43 
ALSPAC (n = 720) (Table  3) for the 10 FDR-significant 
CpG sites. All 10 CpGs exhibited the same direction of 
association, while 3 of these associations were statistically 
significant after cell-mix adjustment (p-values < 0.05) 
(Table 3; Additional file 2: Table S3): cg04359558 (LITAF), 
cg13753183 (APTX), and cg16658191 (HK1). These CpGs 
have been annotated with genomic information and 
function (Table 4). Differences in the distributions of cell-
types are presented in Additional file 2: Table S4).
Adjusting for estimated cell mixtures attenuated 
most ORs, and led to some discordance between IOW 
and ALSPAC, with only cg04359558 and cg16658191 
exhibiting significant associations with asthma in both 
cohorts after cell-type adjustments. Only our top-hit 
(cg16658191) was significantly associated with asthma in 
all models across both cohorts.
Some of the tested CpGs were observed to have 
moderate-to-strong Spearman correlations (cg06866208, 
cg07948085, cg09241885, cg11310939, cg13753183, 
cg16658191) with the proportions of estimated eosinophils 
(range of rho values: − 0.51 to − 0.59, p-values < 0.0001) 
and were also moderately correlated with each other (range 
of rho values: 0.26 to 0.49, p-values < 0.0001) (Additional 
file 3: Figure S2), suggesting that methylation levels at these 
CpGs may be partial markers of eosinophils.
Given the inconsistent confounding effects of cell-
type, we considered cg16658191 within the hexokinase-1 
(HK1) gene as the finding with the most consistent 
evidence for an association with asthma and carried this 
CpG forward for cross-sectional analyses with allergy, 
inflammation and lung-function, as well as prospective 




IOW F1 Sample (18 years of age, n=370)
(Stage-1 Sample n=91):
RF Feature Selection to 
select CpGs that improve 
classification of asthma 
(Stage-2 Sample n=279):
Identify which CpGs are associated 
with asthma while controlling false-
positives. Select CpGs with logistic 
regression q-values < 0.05 
(FDR = 5%)
Replication Phase:
ALSPAC Sample (17 years of age, n=720)
Assess crude and cell-mix adjusted associations for asthma 
at 10 CpG sites), p-values < 0.05 successfully replicated
Compare associations to those from full IOW Sample:
IOW F1 Sample (n=370)
Prospective Follow-Up with Infants:
IOW F2 Sample (DNAm n=111 & Expression n=82 at birth)
Focus on most robust 
association
5 CpGs Replicated via
Crude or Adjusted 
Fig. 1 Flowchart of analyses and results for each stage of the study. IOW Isle of Wight, F1 first generation sample, F2 second generation sample, 
ALSPAC Avon Longitudinal Study of Parents and Children, DNAm DNA methylation
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HK1 DNA methylation is associated with allergy, 
inflammation and lung function
We found that DNAm at cg16658191 was lower among 
those with atopy (T-test: HK1 p-value < 0.001) and 
had an inverse non-linear association with logFeNO 
(rho = − 0.22, p-value < 0.0001), suggesting that it is 
involved in allergic sensitization and airway inflammation. 
Additionally, those with lower DNAm at this locus tended 
to have lower  FEV1/FVC (rho = 0.10, p-value = 0.057) 
and  FEF25–75% (rho = 0.095, p-value = 0.075) though these 
correlations were not statistically significant (Fig. 2).
Prospective follow‑up for HK1 associations in infants
We then performed follow-up analyses for associations of 
our top locus, cg16658191, with wheeze during infancy and 
variations in gene-expression in the IOW F2 sample. Infants 
with lower levels of cord blood DNAm at cg16658191 had 
greater odds of wheeze without cold within the 1st year of 
Table 1 Baseline characteristics among those with and without asthma in the IOW F1 sample (18 years of age)
FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, FeNO fractional-exhaled nitric oxide
a Due to heavy positive skew of FeNO, medians (interquartile ranges) are presented here
Categorical factors Asthmatics (n = 51) Non‑asthmatics (n = 319)
n Percent n Percent
Female sex 35 68.6 210 65.8
Atopy 33 66.0 93 29.5
Continuous factors n Mean (SD) n Mean (SD)
FVC 49 4.50 (0.874) 307 4.48 (0.857)
FEV1 49 3.74 (0.750) 307 3.94 (0.719)
FEV1/FVC Ratio 49 0.83 (0.088) 307 0.88 (0.064)
FeNOa 47 21.00 (60.00) 300 14.0 (10.50)
Estimated cell proportions n Mean (SD) n Mean (SD)
CD8+ T-Cells 51 0.101 (0.082) 319 0.098 (0.054)
CD4+ T-Cells 51 0.121 (0.052) 319 0.110 (0.047)
Natural Killer Cells 51 0.055 (0.061) 319 0.070 (0.062)
B-Cells 51 0.046 (0.023) 319 0.039 (0.024)
Monocytes 51 0.072 (0.024) 319 0.074 (0.024)
Eosinophils 51 0.045 (0.045) 319 0.021 (0.025)
Neutrophils 51 0.558 (0.118) 319 0.589 (0.114)
Table 2 Crude and adjusted associations between M-values and asthma in the IOW F1 (18 years of age, n = 370) sample 
via logistic regression
OR odds ratio, CI 95% confidence intervals, IOW Isle of Wight, pct. percentile
a Adjusted for cell mixture and sex
CpG annotations DNAm distribution Crude model Adjusted  modela
CpG ID Gene Median (5th, 95th pct.) OR CI OR CI
cg00100703 UNC45B 0.93 (0.89, 0.95) 0.12 (0.05, 0.28) 0.18 (0.06, 0.50)
cg01069468 SYNGAP1 0.88 (0.84, 0.91) 0.12 (0.04, 0.31) 0.39 (0.08, 1.72)
cg04359558 LITAF 0.93 (0.87, 0.96) 0.23 (0.12, 0.42) 0.34 (0.17, 0.68)
cg06866208 – 0.81 (0.73, 0.84) 0.14 (0.05, 0.34) 0.40 (0.09, 1.72)
cg07948085 – 0.89 (0.84, 0.93) 0.16 (0.07, 0.34) 0.26 (0.09, 0.74)
cg09241885 C20orf118 0.89 (0.80, 0.93) 0.29 (0.16, 0.49) 0.41 (0.17, 0.99)
cg11310939 MARCH3 0.91 (0.86, 0.92) 0.19 (0.09, 0.40) 0.45 (0.15, 1.44)
cg13753183 APTX 0.90 (0.86, 0.93) 0.11 (0.04, 0.30) 0.30 (0.06, 1.38)
cg16658191 HK1 0.93 (0.89, 0.95) 0.12 (0.05, 0.27) 0.17 (0.04, 0.57)
cg25578728 CHD7 0.90 (0.85, 0.94) 0.24 (0.11, 0.46) 0.27 (0.11, 0.60)
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life (Table 5), though adjustments for estimated cell-types 
confounded this association, particularly due to a strong 
correlation with nRBCs (rho = − 0.84, p-value < 0.0001) 
and moderate correlation with granulocytes (rho = 0.59, 
p-value < 0.0001). Additionally, DNAm at cg16658191 
was inversely associated with the expression of HK1 
(rho = − 0.22, p-value = 0.039) and increased expression 
of HK1 was associated with increased odds of wheeze 
without cold and odds of any wheeze, during the 1st year of 
life. Interestingly, these associations became stronger after 
adjusting for cellular heterogeneity (Table 5).
Discovery of epigenomic loci associated with asthma 
(traditional EWAS approach)
Finally, we examined DNAm-asthma associations using a 
standard EWAS approach, regressing methylation levels 
for all CpGs on asthma status in unadjusted models and 
models adjusted for sex,  CD4+ T-cells,  CD8+ T-cells, 
monocytes, eosinophils, natural killer, and granulocytes. 
In the unadjusted models, 148 CpGs were significantly 
associated (FDR 5%) with asthma status. However, 
adjusting for sex and cell mixture resulted in attenuation 
of most of these results and none of the adjusted models 
produced FDR-significant associations. We compared the 
results from our models, unadjusted (Additional file  2: 
Table S5) and adjusted (Additional file 2: Table S6) that 
yielded p-values < 0.001, to the results from a prior EWAS 
in ALSPAC for current asthma and current wheeze at 
ages 7.5 and 16.5  years that yielded p-values < 0.001 
[10]. Of the 674 CpGs that were associated with asthma 
(p-value < 0.001) in IOW prior to cell-type adjustment, 
20 CpGs yielded p-values < 0.001 for all four models in 
ALSPAC (Additional file  2: Table  S7). However, only 
one CpG yielded a p-value < 0.001 in the IOW and 
a p-value < 0.001 in ALSPAC when adjusting for cell 
mixture, and that was cg16658191. We also compared 
our results to the asthma-associated CpGs identified in a 
meta-analysis of children between the ages 4 and 8 years 
old [18] at the 11 (out of 14) sites that passed QC in our 
study. Although all 11 sites yielded nominally significant 
inverse associations with asthma in IOW (Additional 
file  2: Table  S8) only cg10142874 retained even a 
nominal association with asthma in IOW after cell-mix 
adjustment (p-value = 0.013).
Discussion
We performed an epigenome-wide association study 
of current asthma in the IOW cohort utilizing two 
statistical approaches and a replication analysis in an 
independent population. We identified that lower DNAm 
at cg16658191 within the 1st exon of HK1 as a marker 
of current asthma. This CpG was identified via random 
forest feature selection and confirmed using standard 
EWAS, and was replicated within an independent cohort 
(ALSPAC). We then produced similar associations 
between DNAm of cg16658191 and the expression of 
HK1 in cord blood with infant wheeze in the children of 
the IOW cohort. We also observed functional evidence 
Table 3 Replication of  crude and  adjusted associations 
between  M-values and  asthma in  the  ALSPAC (17  years 
of age, n = 720) sample via logistic regression
OR odds ratio, CI 95% confidence intervals, ALSPAC Avon Longitudinal Study of 
Parents and Children, pct. percentile
a Adjusted for cell mixture, sex, and batch variables
CpG annotations Crude model Adjusted  modela
CpG ID Gene OR CI OR CI
cg00100703 UNC45B 0.71 (0.52, 0.96) 0.77 (0.52, 1.15)
cg01046943 NUP210 0.93 (0.71, 1.20) 0.83 (0.62, 1.11)
cg04359558 LITAF 0.75 (0.56, 1.00) 0.61 (0.40, 0.94)
cg06866208 – 1.01 (0.70, 1.44) 0.86 (0.38, 1.97)
cg07948085 – 0.63 (0.43, 0.91) 0.70 (0.45, 1.06)
cg09241885 C20orf118 0.85 (0.64, 1.13) 0.75 (0.51, 1.10)
cg11310939 MARCH3 0.78 (0.60, 1.02) 0.90 (0.65, 1.24)
cg13753183 APTX 0.76 (0.58, 1.00) 0.67 (0.46, 0.98)
cg16658191 HK1 0.51 (0.37, 0.72) 0.57 (0.38, 0.87)
cg25578728 CHD7 0.73 (0.53, 1.02) 0.78 (0.50, 1.24)
Table 4 Annotations and  biological functions of  genes associated with  CpG sites associated with  asthma 
in the replication study via either the adjusted or unadjusted models
Ch Chromosome, UTR untranslated region
CpG ID Region Gene ID Gene name Function
cg04359558 Body LITAF Lipopolysaccharide-
Induced TNF-α 
Factor
DNA binding-protein that promotes inflammatory cytokine expression; involved 
in apoptotic signaling and inhibition of proliferation [46, 47]
cg13753183 Body; 1st Exon; 5′UTR APTX Aprataxin Involved in DNA repair; mutations have been associated with ataxia-ocular 
apraxia [49]
cg16658191 Body; 1st Exon HK1 Hexokinase-1 Involved in glucose metabolism [34] and inhibition of apoptotic signaling [40]
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Fig. 2 Variation in DNAm (beta-values) at cg16658191 by a adolescent atopy, b log(FeNO), c  FEV1/FVC, and d  FEF25–75%, within the IOW F1 sample. 
HK1, hexokinase-1; FeNO, fractional exhaled nitric oxide;  FEV1/FVC, forced expiratory volume in one second divided by the forced vital capacity; 
 FEF25–75%, forced expiratory flow at 25–75% of forced vital capacity
Table 5 Associations between cord blood DNAm at cg16658191 and expression of HK1 with infant wheeze without cold 
and any wheeze within the IOW F2 sample
OR, Odds Ratio; CI, 95% confidence interval; CB, cord blood; HK1, hexokinase-1; w/o, without
a Adjusted for infant sex and season of birth
b Adjusted for infant sex, season of birth, and cell mixture
Exposure Outcomes
Wheeze without cough/cold Any wheeze
OR p‑value 95% CI OR p‑value 95% CI
cg16658191 (n = 111)
 Crude model 0.23 0.0097 (0.07–0.68) 0.58 0.23 (0.23–1.41)
 Adjusted model  1a 0.21 0.0062 (0.06–0.61) 0.57 0.23 (0.22–1.40)
 Adjusted model  2b 0.37 0.30 (0.05–2.35) 2.42 0.27 (0.52–12.18)
HK1 (A_23_P217958) (n = 82)
 Crude model 3.14 0.0183 (1.26–8.62) 3.44 0.0045 (1.54–8.59)
 Adjusted model  1a 3.62 0.015 (1.34–10.95) 3.22 0.0075 (1.42–8.08)
 Adjusted model  2b 7.51 0.0085 (1.89–40.50) 4.89 0.0087 (1.63–18.15)
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of HK1′s involvement in infant wheeze using gene 
expression data that exhibited the expected associations 
with infant wheeze, given that promoter and first 
exon methylation are most commonly associated 
with repression of gene expression [6, 33]. DNAm at 
cg16658191, which is within the body and/or first exon, 
was inversely associated with HK1 expression and we 
showed that higher expression of HK1 was predictive of 
wheezing without a cold during infancy. The HK1 gene 
resides in 10q22.1 and encodes a protein that is integral in 
the first step of glycolysis [34] and in apoptotic resistance 
[35]. The consistency of these associations across 
different ages, with different respiratory outcomes, and 
utilizing both DNAm and gene expression as predictors, 
suggests that this gene may play an important role in the 
predisposition for wheezing and/or asthma.
We found that many of our RF-identified hits, 
including cg16658191, were inversely correlated with 
eosinophil counts in adult blood, similar to what was 
observed by Arathimos et al. [10]. However, confounding 
by cell-mixture may not be limited to eosinophil 
proportions. For instance, because of its crucial role 
in glucose metabolism, HK1 is highly expressed by 
erythrocytes [36]. This is consistent with the strong 
inverse correlation we observed between cg16658191 and 
estimated nRBC proportions in cord blood, which could 
indicate prematurity, restricted growth, or pregnancy 
complications [37]. Additionally, premature and low birth 
weight neonates are predisposed to early-life respiratory 
morbidity [38, 39]. However, adjustments for weeks of 
gestation did not appreciably alter our results (data not 
shown).
Though DNAm at cg16658191 may, in part, be a marker 
of high eosinophil counts in adult blood and nRBCs in 
cord blood, we found that, in addition to the relationship 
between DNAm and asthma, HK1 expression was 
strongly and significantly associated with infant wheeze 
even after cell-type adjustments. These findings suggest 
a role for DNAm of the HK1 gene in asthma and wheeze 
etiology that is independent of cell-type proportions, 
possibly through differential epigenetic regulation within 
a subset of asthma-associated cell-types. However, it is 
difficult to disentangle such relationships in studies that 
utilize tissues composed of mixed cell populations, such 
as blood. HK1 is involved in apoptotic resistance via 
binding to and stabilizing the mitochondrial membrane, 
whereas the dissociation of HK1 from the membrane 
makes those cells more susceptible to apoptosis [40]. 
Up-regulation of HK1 resulting in increased apoptotic 
resistance has been observed in cancerous cells [41] and 
HIV-1 infected macrophages [42]. Apoptotic-resistant 
pro-inflammatory cells are known to lead to prolonged 
inflammation [43] and apoptosis appears to be delayed in 
neutrophils [44] and T-lymphocytes [45] of asthmatics. 
This provides a possible mechanism through which HK1 
epigenetic regulation and expression by immune cells 
may be involved in asthma and wheeze etiology.
We also examined relationships between DNAm 
and asthma using a more traditional EWAS approach, 
regressing the methylation beta-values for each loci 
on asthma status, and compared our findings to two 
recent EWAS, one performed by ALSPAC [10] and 
a meta-analysis of childhood asthma from multiple 
European cohorts [18]. This approach identified 148 
CpGs that were significantly associated (5% FDR) with 
asthma prior to cell-type adjustment, and no FDR-
significant findings after adjustment. We also found 
very little consistency in observed associations between 
our study and the ALSPAC study after adjusting for cell 
mixture. Only cg16658191 demonstrated an association 
with current asthma and wheeze in the fully adjusted 
models (p < 0.001) in both the IOW and ALSPAC. When 
comparing our traditional EWAS results to a meta-
analysis of childhood asthma, only cg10142874 from 
that meta-analysis yielded an even nominally-significant 
association with asthma in IOW after cell-mixture 
adjustment.
Strengths of our study included the use of multiple 
samples to discover and replicate our findings, supported 
by gene expression studies, and the use of a validated 
tool, the ISAAC core questionnaire, to define current 
asthma status. However, it is also important to recognize 
this study’s limitations. One limitation is that detection 
of CpGs in the IOW birth cohort and the replication 
study in ALSPAC investigated concurrent associations. 
Hence, reverse causation in which asthma may result 
in differential methylation of HK1 cannot be excluded. 
Differences between the two cohorts, confounding 
by cell-mixture, errors in cell-mixture estimates, and 
asthma heterogeneity may have limited replicability of 
more loci after additional adjustments. The discovery 
and replication samples were similar in sex-distribution, 
prevalence of asthma, and age, but differed in estimated 
cell-type distributions (Additional file  2: Table  S4). 
Additionally, though the estimated cell-proportions are 
imperfect, we utilized the gold standard for predicting cell 
mixtures from DNAm arrays [27] and comprehensively 
evaluated the impact of cellular heterogeneity on 
our findings. There is also the possibility of residual 
confounding, perhaps by genotype. Numerous SNPs have 
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been implicated as asthma susceptibility loci, and some 
SNPs have been shown to influence the methylation 
status of CpG sites. We cannot rule out the possibility 
that our findings are markers of upstream genetic effects 
on both DNA methylation and asthma susceptibility. It 
is also important to point out that the relationships we 
observed between DNAm and expression of HK1 in cord 
blood with infant wheeze, cannot be directly extrapolated 
to asthma. It is unclear whether DNAm patterns of HK1 
in cord blood are informative for the later development 
of asthma, although our findings provide evidence that 
lower DNAm and increased expression of HK1 in cord 
blood are associated with wheezing in the 1st year of life. 
Finally, asthma is a heterogeneous condition, in which 
different phenotypes may arise via different underlying 
physiological mechanisms [3]. We showed that HK1 
DNAm levels were also strongly associated with atopy 
and FeNO, which may indicate that the regulation of 
this gene is particularly important in allergic-asthma. 
This also raises the possibility that some of our other 
discovered, but not replicated, loci may be associated 
with specific asthma-phenotypes. If the prevalences of 
these phenotypes differ between IOW and ALSPAC, 
this may have contributed to the discordant results. 
Interestingly, some of the CpGs with discordant results 
between the two cohorts were within genes or genomic 
regions that have previously been associated with asthma 
or are involved in apoptotic signaling, like HK1. For 
instance, cg04359558 is within the body of LITAF, a gene 
that encodes a DNA-binding protein that promotes the 
expression of TNF-α and other cytokines known to be 
involved in pro-inflammatory and apoptotic signaling 
[46, 47]. UNC45B, annotated to cg00100703, lies within 
the asthma susceptibility region 17q12–21 [48], though 
this particular gene has not previously been linked to 
asthma.
Conclusions
In summary, we discovered a novel epigenetic association 
with adolescent asthma at cg16658191 within HK1, 
whose DNAm and expression levels in cord blood were 
also associated with infant wheeze without cold. In 
addition, the association of cg16658191 with asthma was 
replicated in an independent cohort. However, we also 
found that our findings may be affected, at least in part, by 
heterogeneous cell-mixtures. Further research is required 
to determine whether these observed associations are 
reproducible in other populations, particularly with 
different racial and ethnic characteristics, and whether 
some of these loci are differentially regulated between 
those with and without asthma in specific cell-type 
populations such as eosinophils.
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